The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression

Journal of Neuroscience

Volumn 30, Issue 18, 2010, Pages 6282-6290

  Tasan, Ramon O ^a   Nguyen, Ngoc Khoi ^a   Weger, Stefan ^b   Sartori, Simone B ^a   Singewald, Nicolas ^a   Heilbronn, Regine ^b   Herzog, Herbert ^c   Sperk, Günther ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; NEUROPEPTIDE Y; NEUROPEPTIDE Y2 RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DEPRESSION; EMBRYO; EMOTION; GENE; GENE DELETION; HUMAN; HUMAN CELL; INTERNEURON; LOCUS CERULEUS; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PHENOTYPE; PRESYNAPTIC INHIBITION; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY MECHANISM; STRIA TERMINALIS; Y2 GENE;

AMYGDALA; ANIMALS; ANXIETY; DEPRESSION; DISEASE MODELS, ANIMAL; LOCUS COERULEUS; MALE; MICE; MICE, KNOCKOUT; NEUROPEPTIDE Y; RECEPTORS, NEUROPEPTIDE Y; SEPTAL NUCLEI;

EID: 77951825354     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0430-10.2010     Document Type: Article

References (48)

1. Alheid GF (2003) Extended amygdala and basal forebrain. Ann N Y Acad Sci 985:185-205.
2. Bacchi F, Mathé AA, Jiménez P, Stasi L, Arban R, Gerrard P, Caberlotto L (2006) Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Peptides 27:3202-3207. (Pubitemid 44738169)
3. Bannon AW, Seda J, Carmouche M, Francis JM, Norman MH, Karbon B, McCaleb ML (2000) Behavioral characterization of neuropeptide Y knockout mice. Brain Res 868:79-87. (Pubitemid 30332345)
4. Bellmann R, Widmann R, Olenik C, Meyer DK, Maas D, Marksteiner J, Sperk G (1991) Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures. J Neurochem 56:525-530. (Pubitemid 21901993)
5. Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ (1989) A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berl) 97:277-279. (Pubitemid 19040176)
6. Broqua P, Wettstein JG, Rocher MN, Gauthier-Martin B, Junien JL (1995) Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav Pharmacol 6:215-222.
7. Caberlotto L, Fuxe K, Hurd YL (2000) Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum. J Chem Neuroanat 20:327-337. (Pubitemid 32162890)
8. Chen G, van den Pol AN (1996) Multiple NPY receptors coexist in pre- and postsynaptic sites: inhibition of GABA release in isolated self-innervating SCN neurons. J Neurosci 16:7711-7724. (Pubitemid 26389710)
9. Colmers WF, Klapstein GJ, Fournier A, St-Pierre S, Treherne KA (1991) Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Br J Pharmacol 102:41-44.
10. Crawley J, Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:167-170. (Pubitemid 11225713)
11. Crawley JN, Paylor R (1997) A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav 31:197-211.
12. Dong HW, Petrovich GD, Swanson LW (2001) Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Brain Res Rev 38:192-246. (Pubitemid 34066502)
13. Dumont Y, Fournier A, St-Pierre S, Quirion R (1993) Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J Neurosci 13:73-86. (Pubitemid 23028729)
14. Ebner K, Rupniak NM, Saria A, Singewald N (2004) Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc Natl Acad Sci U S A 101:4280-4285. (Pubitemid 38405920)
15. Furtinger S, Pirker S, Czech T, Baumgartner C, Ransmayr G, Sperk G (2001) Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 21:5804-5812. (Pubitemid 32692179)
16. Grimm D, Kay MA, Kleinschmidt JA (2003) Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol Ther 7:839-850. (Pubitemid 36790261)
17. Gustafson EL, Card JP, Moore RY (1986) Neuropeptide Y localization in the rat amygdaloid complex. J Comp Neurol 251:349-362. (Pubitemid 16032952)
18. Hall CS (1934) Emotional behavior in the rat: I. Defecation and urination as measures of individual differences in emotionality. J Comp Psychol 1:385-403.
19. Harro J, Oreland L (2001) Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus. Brain Res Brain Res Rev 38:79-128. (Pubitemid 34066497)
20. Heilig M (1995) Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept 59:201-205.
21. Heilig M, McLeod S, Brot M, Heinrichs SC, Menzaghi F, Koob GF, Britton KT (1993) Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8:357-363. (Pubitemid 23162961)
22. Holmes A (2001) Targeted gene mutation approaches to the study of anxiety-like behavior in mice. Neurosci Biobehav Rev 25:261-273.
23. Karlsson RM, Choe JS, Cameron HA, Thorsell A, Crawley JN, Holmes A, Heilig M (2008) The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice. Psychopharmacology (Berl) 195:547-557. (Pubitemid 350160495)
24. Kash TL, Winder DG (2006) Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 51:1013-1022.
25. Kaspar BK, Vissel B, Bengoechea T, Crone S, Randolph-Moore L, Muller R, Brandon EP, Schaffer D, Verma IM, Lee KF, Heinemann SF, Gage FH (2002) Adeno-associated virus effectively mediates conditional gene modification in the brain. Proc Natl Acad Sci U S A 99:2320-2325. (Pubitemid 34169059)
26. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593-602. (Pubitemid 40973434)
27. LeDoux JE, Iwata J, Cicchetti P, Reis DJ (1988) Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 8:2517-2529.
28. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92:180-185.
29. McDonald AJ (1989) Coexistence of somatostatin with neuropeptide Y, but not with cholecystokinin or vasoactive intestinal peptide, in neurons of the rat amygdala. Brain Res 500:37-45.
30. McDonald AJ (2003) Is there an amygdala and how far does it extend? An anatomical perspective. Ann N Y Acad Sci 985:1-21.
31. McDonald AJ, Pearson JC (1989) Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala. Neurosci Lett 100:53-58.
32. Millan MJ (2003) The neurobiology and control of anxious states. Prog Neurobiol 70:83-244.
33. Nakajima M, Inui A, Asakawa A, Momose K, Ueno N, Teranishi A, Baba S, Kasuga M (1998) Neuropeptide Y produces anxiety via Y2-type receptors. Peptides 19:359-363. (Pubitemid 28097936)
34. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates, Ed 2. San Diego: Academic.
35. Redrobe JP, Dumont Y, Herzog H, Quirion R (2003) Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav Brain Res 141:251-255. (Pubitemid 36542973)
36. Sainsbury A, Schwarzer C, Couzens M, Fetissov S, Furtinger S, Jenkins A, Cox HM, Sperk G, Hökfelt T, Herzog H (2002) Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci U S A 99:8938-8943. (Pubitemid 34693662)
37. Sajdyk T, Johnson P, Fitz S, Shekhar A (2008) Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior. J Psychopharmacol 22:633-641.
38. Sajdyk TJ, Schober DA, Smiley DL, Gehlert DR (2002) Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala. Pharmacol Biochem Behav 71:419-423.
39. Schmued LC, Stowers CC, Scallet AC, Xu L (2005) Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 1035:24-31.
40. Sosulina L, Schwesig G, Seifert G, Pape HC (2008) Neuropeptide Y activates a G-protein-coupled inwardly rectifying potassium current and dampens excitability in the lateral amygdala. Mol Cell Neurosci 39:491-498.
41. Stanić D, Brumovsky P, Fetissov S, Shuster S, Herzog H, Hökfelt T (2006) Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals. J Comp Neurol 499:357-390.
42. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85:367-370. (Pubitemid 15123115)
43. Swanson LW, Petrovich GD (1998) What is the amygdala? Trends Neurosci 21:323-331.
44. Tasan RO, Lin S, Hetzenauer A, Singewald N, Herzog H, Sperk G (2009) Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience 158:1717-1730.
45. Tschenett A, Singewald N, Carli M, Balducci C, Salchner P, Vezzani A, Herzog H, Sperk G (2003) Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 18:143-148. (Pubitemid 36920855)
46. Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M (1993) Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259:528-531. (Pubitemid 23058713)
47. Wang JW, David DJ, Monckton JE, Battaglia F, Hen R (2008) Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci 28:1374-1384. (Pubitemid 351231535)
48. Zolotukhin S, Potter M, Zolotukhin I, Sakai Y, Loiler S, Fraites TJ Jr, Chiodo VA, Phillipsberg T, Muzyczka N, Hauswirth WW, Flotte TR, Byrne BJ, Snyder RO (2002) Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28:158-167. (Pubitemid 35341079)